News

Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

July 13, 2026 SDBN Comments Off

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel, allogeneic, “off the shelf”, cell therapies for serious medical conditions, today provided an update on COR1, […]

First-of-its-Kind Surgery Performed on Western Lowland Gorilla at the San Diego Zoo Safari Park

July 13, 2026 SDBN Comments Off

UC San Diego Health surgeons and wildlife health experts at the San Diego Zoo Safari Park team up to perform the world’s first reported mastoidectomy on a gorilla SAN DIEGO, July 13, 2026 /PRNewswire/ — […]

StockWatch: Insilico Projects Profit, Revenue Leaps as AI-Developed Lead Candidate Moves to Phase III

July 12, 2026 SDBN Comments Off

Insilico Medicine (Hong Kong Exchange: 3696), an AI-based drug developer whose profile within biopharma has risen with its recent collaborations with industry giants, has offered investors an upbeat revenue and profit forecast for the first […]

Macrophage Membrane-Derived Nanoparticles Shows Potential Against Candida Infections

July 10, 2026 SDBN Comments Off

By using tiny particles made from the membranes of human immune cells, scientists from the University of California, San Diego and the University of Missouri have created antifungal nanoparticles that target Candida albicans, a fungus […]

How Do We Decide Which Climate Projects Are Worth Funding?

July 10, 2026 SDBN Comments Off

Carbon markets do a pretty good job of rewarding projects for reducing or storing carbon but typically overlook other benefits, says UC San Diego School of Global Policy and Strategy economist Teevrat Garg. Click here […]

Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results

July 9, 2026 SDBN Comments Off

Conference Call and Webcast Scheduled for Thursday, July 30 SAN DIEGO, July 9, 2026 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its second quarter 2026 financial results conference call […]

Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

July 9, 2026 SDBN Comments Off

SAN DIEGO, July 9, 2026 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the second quarter 2026 following the close of market on Thursday, July 30, 2026. On the […]

New Report Outlines Potential to Predict Coastal Cliff Collapses

July 9, 2026 SDBN Comments Off

Following a four-year study, scientists at UC San Diego’s Scripps Institution of Oceanography released a new report to determine if an early warning system could potentially detect a landslide before it happens. Click here to […]

Human Study on Qualia Senolytic Featured in International Journal of Molecular Sciences, Showing Potential Aging Benefits

July 9, 2026 SDBN Comments Off

Published research shows potential changes in key senescence-associated proteins from one course of Qualia Senolytic supplementation CARLSBAD, Calif., July 9, 2026 /PRNewswire/ — Senescent cells (sometimes called “zombie cells”) accumulate in the human body as […]

Immune Cells Get Transformed into Fungus-Fighting Nanoparticles

July 9, 2026 SDBN Comments Off

Tiny particles made from the membranes of human immune cells could offer a promising new way to fight fungal infections that are becoming harder to treat. The antifungal nanoparticles target Candida albicans, a fungus responsible […]

Arialys Therapeutics Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of Anti-NMDA Receptor Encephalitis

July 9, 2026 SDBN Comments Off

LA JOLLA, Calif.–(BUSINESS WIRE)– #ANRE–Arialys Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of ANRE Click here to view original post Click Here to Publish/Feature […]

Aureum Therapeutics Announces Successful Prevention of Recurrent Miscarriage using NomiCell™ Stem Cells in Preclinical Studies

July 9, 2026 SDBN Comments Off

Publication in Peer-Reviewed Journal Details Mechanisms of Miscarriage and Provides Potential Solution SAN DIEGO, July 9, 2026 /PRNewswire/ — Aureum Therapeutics, a clinical-stage biotechnology company dedicated to developing immunology-based treatments for recurrent miscarriage and… Click […]

Auxilium Biotechnologies Achieves Historic Space Bioprinting Milestone, Successfully Bioprinting Kidney and Liver Tissues in Orbit for the First Time

July 9, 2026 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)– #3Dprinting–Auxilium Biotechnologies successfully bioprinted kidney and liver tissues aboard the International Space Station (ISS) for the first time in history. Click here to view original post Click Here to Publish/Feature Your Company […]

RYBODYN AWARDED $1.3M DOW GRANT TO ADVANCE NOVEL ANTIBODY THERAPIES FOR LUNG CANCER

July 9, 2026 SDBN Comments Off

Competitive CDMRP award funds preclinical programs against two cryptic cell-surface targets discovered directly in patient tumors using the company’s AI-powered RyboCypher™ platform and CypherAtlas™ knowledgebase SAN DIEGO, July 9, 2026 /PRNewswire/ — RyboDyn, Inc., a […]

Faculty Symposium Highlights AI’s Strengths in Higher Ed Teaching

July 9, 2026 SDBN Comments Off

At the Faculty AI Symposium in late May 2026, Chancellor Pradeep K. Khosla highlighted the power of UC San Diego’s faculty and the cutting-edge solutions they have built to integrate AI tools into their teaching […]

Amprion To Expand Diagnostic Testing For Neurodegenerative Disorders With Investment From Decathlon Capital Partners

July 8, 2026 SDBN Comments Off

Agreement provides flexible amortization without dilution or loss of management control SAN DIEGO, July 8, 2026 /PRNewswire/ — Amprion, Inc., a global leader advancing diagnosis of neurodegenerative disorders through seed-amplification testing, has reached an agreement […]

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

July 8, 2026 SDBN Comments Off

SAN DIEGO, July 08, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a biotechnology company pioneering the development of targeted genetic medicine, today announced that in connection with the appointment of Sandra […]

Could Geoengineering Work to Tamp Down Super El Niños?

July 8, 2026 SDBN Comments Off

A 2019 Australian bushfire provided a case study enabling researchers to consider whether the geoengineering technique called marine cloud brightening could diminish the destructive effects of major El Niño events in the future. Click here […]

Local PBMC Isolation Enables Four-Hour Processing in San Diego

July 8, 2026 SDBN Comments Off

Fast, local cryopreservation is a consistent bottleneck for autologous cell therapy developers, even in major cell and gene therapy hubs. For the peripheral blood mononuclear cells (PBMCs) that form the foundation of immunotherapies, vaccine development […]

Surgeons Use Teleoperated Humanoid Robots to Perform Live Surgery – a World First

July 8, 2026 SDBN Comments Off

For the first time, two teleoperated humanoid robots have been used to complete two surgeries during a preclinical trial, researchers report in the July 8 issue of the journal Nature. Click here to view original […]

Bifrost Biosystems Pens Agreement with Illumina for Supply of Sequencing Chemistry for Optical Pooled Screening Platform

July 8, 2026 SDBN Comments Off

BERKELEY, Calif.–(BUSINESS WIRE)– #AIDrugDiscovery–Bifrost Biosystems today announced that it has secured a commercial supply agreement with Illumina enabling integration of Illumina’s industry-standard sequencing-by-synthesis (SBS) chemistry into its optical pooled screening (OPS) platform slated to be […]

Germline?Targeting HIV Vaccine Generates Broadly Neutralizing Antibodies in Primates

July 7, 2026 SDBN Comments Off

For years, HIV has resisted traditional vaccine strategies. The virus’s staggering antigenic diversity, rapid mutation rate, and glycan?shielded envelope have made it extraordinarily difficult for the immune system to generate antibodies capable of recognizing HIV’s […]

Movemedical Launches Ask Move AI, the First AI Assistant Purpose-Built for Med Device Field Operations

July 7, 2026 SDBN Comments Off

Mobile-first AI assistant built on 15+ years of surgical case data gives field reps a conversational interface for every step of their case workflow. SAN DIEGO, July 7, 2026 /PRNewswire/ — Movemedical, the leading field […]

Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout

July 7, 2026 SDBN Comments Off

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, the companies said, in a deal that would expand the buyer’s rare disease portfolio beyond its anchor indication of cystic fibrosis (CF), by […]

Study: Biodiversity Hotspots in American West Face Extinction

July 7, 2026 SDBN Comments Off

A comprehensive study of more than 1,100 springs in the American West warns that critical biodiversity hotspots are facing a mounting extinction crisis. Click here to view original post Click Here to Publish/Feature Your Company […]

Las Vegas Global Economic Alliance Showcases Southern Nevada’s Growing Bioscience Ecosystem at BIO International Convention 2026

July 7, 2026 SDBN Comments Off

Nevada Pavilion connects with hundreds of global biotechnology leaders. LAS VEGAS, July 7, 2026 /PRNewswire/ — The Las Vegas Global Economic Alliance (LVGEA) joined regional partners at the BIO International Convention 2026, held June 22-25 […]

Nucleus Biologics Launches CRAIC™ Formulation Finder, Bringing Conversational AI to Cell Culture Media and Buffer Development

July 7, 2026 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)– #cellandgenetherapy–Nucleus Biologics launches CRAIC™, a conversational AI assistant in NB-Lux™ AI that accelerates cell culture media and buffer formulation. Click here to view original post Click Here to Publish/Feature Your Company or […]

FDA Clears CliniComp PACS Viewer (MIMPS), Unifying Diagnostic Imaging, Enterprise EHR, and Native AI in a Single Platform

July 7, 2026 SDBN Comments Off

PACS fuels faster, more precise diagnosis and patient triaging for busy healthcare providers to assist with decision-making SAN DIEGO, July 7, 2026 /PRNewswire/ — CliniComp, a pioneer in high-performing, reliable, electronic health record (EHR) solutions, […]

Arnatar Therapeutics Receives China NMPA Clearance to Initiate First-in-Human Study of ART5, a First-in-Class Up-Regulating ASO Designed to Restore Polycystin-1 for the Treatment of ADPKD

July 7, 2026 SDBN Comments Off

SAN DIEGO and SUZHOU, China, July 07, 2026 (GLOBE NEWSWIRE) — Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, today announced that the Center for Drug Evaluation (CDE) of China’s […]

Eject! Bacteria Discovered with the Ability to Jettison Cells as a Survival Mechanism

July 7, 2026 SDBN Comments Off

Researchers have observed a cell ejection phenomenon in communities of bacteria (biofilms), similar to how jellyfish eject stingers. Biofilms eject cells to ensure the community survives in new colonies. They leveraged the discovery as a […]

Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

First-of-its-Kind Surgery Performed on Western Lowland Gorilla at the San Diego Zoo Safari Park

StockWatch: Insilico Projects Profit, Revenue Leaps as AI-Developed Lead Candidate Moves to Phase III

Macrophage Membrane-Derived Nanoparticles Shows Potential Against Candida Infections

How Do We Decide Which Climate Projects Are Worth Funding?

Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results

Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

New Report Outlines Potential to Predict Coastal Cliff Collapses

Human Study on Qualia Senolytic Featured in International Journal of Molecular Sciences, Showing Potential Aging Benefits

Immune Cells Get Transformed into Fungus-Fighting Nanoparticles

Arialys Therapeutics Announces U.S. FDA Fast Track Designation for ART5803, the First Precision Therapeutic Candidate in Development for the Treatment of Anti-NMDA Receptor Encephalitis

Aureum Therapeutics Announces Successful Prevention of Recurrent Miscarriage using NomiCell™ Stem Cells in Preclinical Studies

Auxilium Biotechnologies Achieves Historic Space Bioprinting Milestone, Successfully Bioprinting Kidney and Liver Tissues in Orbit for the First Time

RYBODYN AWARDED $1.3M DOW GRANT TO ADVANCE NOVEL ANTIBODY THERAPIES FOR LUNG CANCER

Faculty Symposium Highlights AI’s Strengths in Higher Ed Teaching

Amprion To Expand Diagnostic Testing For Neurodegenerative Disorders With Investment From Decathlon Capital Partners

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Could Geoengineering Work to Tamp Down Super El Niños?

Local PBMC Isolation Enables Four-Hour Processing in San Diego

Surgeons Use Teleoperated Humanoid Robots to Perform Live Surgery – a World First

Bifrost Biosystems Pens Agreement with Illumina for Supply of Sequencing Chemistry for Optical Pooled Screening Platform

Germline?Targeting HIV Vaccine Generates Broadly Neutralizing Antibodies in Primates

Movemedical Launches Ask Move AI, the First AI Assistant Purpose-Built for Med Device Field Operations

Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout

Study: Biodiversity Hotspots in American West Face Extinction

Las Vegas Global Economic Alliance Showcases Southern Nevada’s Growing Bioscience Ecosystem at BIO International Convention 2026

Nucleus Biologics Launches CRAIC™ Formulation Finder, Bringing Conversational AI to Cell Culture Media and Buffer Development

FDA Clears CliniComp PACS Viewer (MIMPS), Unifying Diagnostic Imaging, Enterprise EHR, and Native AI in a Single Platform

Arnatar Therapeutics Receives China NMPA Clearance to Initiate First-in-Human Study of ART5, a First-in-Class Up-Regulating ASO Designed to Restore Polycystin-1 for the Treatment of ADPKD

Eject! Bacteria Discovered with the Ability to Jettison Cells as a Survival Mechanism

Want to Save Time?

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox